These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35244061)

  • 1. Effects of Bojungikgi-tang on anorexic patients with atopic dermatitis: A protocol for a randomized, usual care-controlled, assessor-blinded, parallel, pilot clinical trial.
    Lee B; Park HJ; Jung SY; Kwon OJ; Ko MM; Jeong HA; Jung J
    Medicine (Baltimore); 2022 Mar; 101(9):e28965. PubMed ID: 35244061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of an herbal formula, Gwakhyangjeonggi-san on atopic dermatitis with gastrointestinal symptoms: Protocol for a randomized controlled trial.
    Son MJ; Kim MH; Kang M; Kim YE; Jung J; Choi I
    Medicine (Baltimore); 2020 Jul; 99(28):e20675. PubMed ID: 32664064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of So-Cheong-Ryong-Tang in patients with atopic dermatitis and respiratory disorders: Study protocol of a double-blind randomized placebo-controlled trial.
    Kang SJ; Cho HB; Jo EH; Yang GJ; Hong JE; Lee JH; Shim YH; Mun JH; Park MC
    Medicine (Baltimore); 2020 Jan; 99(2):e18565. PubMed ID: 31914034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of Longmu Tang granule for the treatment of atopic dermatitis: study protocol for a single-centred, double-blinded, randomised, placebo-controlled trial.
    Li YQ; Shen TT; Wang QY; Ma MX; Tian FY; She YY; Tao YC; Wang JJ; Chi HY; Lang N; Ren JX
    Trials; 2022 May; 23(1):379. PubMed ID: 35534883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of Yukgunja-Tang for treating anorexia in patients with cancer: The protocol for a pilot, randomized, controlled trial.
    Kang HJ; Jeong MK; Park SJ; Jun HJ; Yoo HS
    Medicine (Baltimore); 2019 Oct; 98(40):e16950. PubMed ID: 31577697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of Soshiho-tang in patients with atopic dermatitis and gastrointestinal disorders: Study protocol for a double-blind, randomized, and placebo-controlled clinical trial.
    Kang SJ; Jo EH; Yang GJ; Shim YH; Hong JE; Park MC
    Medicine (Baltimore); 2019 May; 98(18):e15479. PubMed ID: 31045830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-omics analysis of Gwakhyangjeonggi-san for gastrointestinal complications in atopic dermatitis: A randomized, double-blinded, placebo-controlled, parallel-group clinical trial.
    Ko MM; Shin S; Kim MH; Kang M; Baek MG; Yi H; Son MJ; Jung J
    J Ethnopharmacol; 2024 Jan; 319(Pt 2):117256. PubMed ID: 37778520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of Soshiho-tang in atopic dermatitis patients with gastrointestinal disorders: A double-blinded, randomized, and placebo-controlled clinical trial.
    Lee JH; Jo EH; Jung JY; Kang SJ; Yang GJ; Shim YH; Park MC
    J Ethnopharmacol; 2021 Jun; 274():114006. PubMed ID: 33766759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical application of Jaungo in atopic dermatitis patients: study protocol for a randomized, controlled trial.
    Yun Y; Ko Y; Ahn JH; Jang BH; Kim K; Ko SG; Choi I
    Trials; 2017 Apr; 18(1):176. PubMed ID: 28403910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Chinese herbal formula Huoxiang Zhengqi for atopic dermatitis with dampness pattern (CHARM): a study protocol for a double-blinded randomized controlled trial.
    Xuan M; Guo X; Li H; Xie T; Mo X; Wen Z
    Trials; 2021 Jan; 22(1):67. PubMed ID: 33468222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Hwangryunhaedok-tang (Huang-lian-jie-du-tang, Oren-gedoku-to) for patients with hyperlipidemia: a study protocol for a randomized, double-blind, placebo-controlled, parallel, investigator-initiated clinical trial.
    Lee B; Han K; Park HJ; Kim AR; Kwon OJ; Yang C; Cho CS
    Trials; 2020 Aug; 21(1):750. PubMed ID: 32854756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chinese herbal medicine granules (PTQX) for children with moderate to severe atopic eczema: study protocol for a randomised controlled trial.
    Gu SX; Zhang AL; Coyle ME; Mo X; Lenon GB; Cranswick NE; Chen D; Xue CC
    Trials; 2015 Jul; 16():294. PubMed ID: 26149448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Sihogayonggolmoryeo-tang (Saikokaryukotsuboreito or Chai-Hu-Jia-Long-Gu-Mu-Li-Tang) for insomnia disorder with prehypertension or stage 1 hypertension: A study protocol for a randomized controlled trial.
    Lee B; Jeong YE; Park HJ; Choi YE; Kim H; Kim BY; Yang C; Jung IC
    Medicine (Baltimore); 2020 Jul; 99(29):e20980. PubMed ID: 32702837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial.
    Reich K; Teixeira HD; de Bruin-Weller M; Bieber T; Soong W; Kabashima K; Werfel T; Zeng J; Huang X; Hu X; Hendrickson BA; Ladizinski B; Chu AD; Silverberg JI
    Lancet; 2021 Jun; 397(10290):2169-2181. PubMed ID: 34023009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the efficacy and safety of topical Jaungo application in patients with atopic dermatitis: A pilot randomized, double-blind, placebo-controlled study.
    Ahn JH; Yun Y; Kim MH; Ko SG; Kim KS; Choi I
    Complement Ther Med; 2018 Oct; 40():22-28. PubMed ID: 30219454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Danggwijagyaksan for climacteric syndrome in peri- and postmenopausal women with a blood-deficiency dominant pattern: study protocol for a randomized, double-blind, placebo-controlled pilot trial.
    Kim M; Kim AR; Park HJ; Kwon O; Kim JH; Park EJ; Baek SE; Yoo JE; Lee JH
    Trials; 2018 Jan; 19(1):41. PubMed ID: 29335018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a Chinese herbal medicine for the treatment of atopic dermatitis: a randomised controlled study.
    Liu J; Mo X; Wu D; Ou A; Xue S; Liu C; Li H; Wen Z; Chen D
    Complement Ther Med; 2015 Oct; 23(5):644-51. PubMed ID: 26365443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted anti-staphylococcal therapy with endolysins in atopic dermatitis and the effect on steroid use, disease severity and the microbiome: study protocol for a randomized controlled trial (MAAS trial).
    Totté J; de Wit J; Pardo L; Schuren F; van Doorn M; Pasmans S
    Trials; 2017 Aug; 18(1):404. PubMed ID: 28859690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.